Rare diseases
Investigational molecules
Locations
Back to Italy83 clinical trials in Bolzano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Enzalutamide and Leuprorelin Acetate for Men with High-Risk Nonmetastatic Prostate Cancer After Treatment
ItalyStudy on Radium-223, Docetaxel, and Prednisone for Patients with Bone-Only Metastatic Castration-Resistant Prostate Cancer
ItalyStudy Comparing Panitumumab and Regorafenib Sequence for Patients with Metastatic Colorectal Cancer Resistant to Previous Treatments
ItalyStudy on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
ItalyStudy on Bevacizumab and Erlotinib for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutation
ItalyStudy of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy
ItalyStudy of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma
ItalyStudy on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
ItalyStudy of AZD5305 with Abiraterone Acetate and Darolutamide in Men with Metastatic Castration-Sensitive Prostate Cancer
ItalyStudy of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer
ItalyStudy of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer
ItalyStudy of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on various blood cancers, including Multiple Myeloma and Acute Lymphoblastic Leukemia. Studies evaluate innovative treatment combinations and novel therapeutic approaches.
Several trials are investigating targeted therapies and immunotherapy combinations to improve patient outcomes.
Comprehensive research into various solid cancers, including breast cancer, prostate cancer, and head and neck malignancies. Studies focus on targeted therapies and novel treatment combinations.
Trials explore personalized medicine approaches based on genetic markers and innovative drug combinations.
Clinical investigations of Polymyalgia Rheumatica and other autoimmune disorders, evaluating new biological treatments and therapeutic strategies.
Research focuses on improving treatment outcomes while minimizing steroid dependency.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
